Puerperal Disorders: Clinical Trials

45 trials for Puerperal Disorders, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

45 completed. 45 Phase 2, 8 Phase 3, 5 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 245Completed 45
Phase 38Completed 8
Phase 15Completed 5

Follow Puerperal Disorders: new trials by email Literature Review of Puerperal Disorders trials Research Report on Puerperal Disorders

Trials (filtered) newest first · largest first

All 45 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy of MI078 Capsules in Treating Postpartum Depression
MI078 capsule dose 1, MI078 capsule dose 2, placebo - Postpartum Depression
Phase 2CompletedNanjing Minova Pharmaceutical Co., Ltd.722024-09-092026-06-25
RE104 Safety and Efficacy Study in Postpartum Depression
RE104 for Injection - Postpartum Depression
Phase 2CompletedReunion Neuroscience Inc842024-06-142026-05-14
A Study to Assess the Efficacy, Safety, and Tolerability of Oral NORA520 in Adults With Severe Postpartum Depression
NORA520 Dose 1, NORA520 Dose 2, Placebo - Depression, Postpartum, Postpartum Depression
Phase 2CompletedTWi Biotechnology, Inc.932024-03-282026-07-31
A Study of BRII-296 in Adults With Severe Postpartum Depression (PPD)
BRII-296, Depo Medrol - Severe Postpartum Depression
Phase 2CompletedBrii Biosciences Limited112023-09-292025-01-27
Efficacy of Carbetocin in Prevention of Postpartum Hemorrhage in Obese Versus Non Obese Women
Carbetocin 100 Microgram/mL Solution for Injection - Obesity, Maternal, Post Partum Hemorrhage
Phase 1 / Phase 2CompletedCairo University1502023-07-062024-01-22
The SUPPORT Study: Effectiveness and Usability of a Web-Enabled Resource for Postpartum Mental Health
Postpartumcare.ca (Web-Enabled Intervention) - Postpartum Depression, Postpartum Anxiety
Phase 2CompletedUniversity of British Columbia1032022-04-202023-05-10
Tranexamic Acid Versus Sublingual Misoprostol in Reducing Blood Loss During Elective CS in High Risk Cases
Misoprostol, Tranexamic acid, Oxytocin - Post Partum Hemorrhage
Phase 2CompletedCairo University3452020-01-202025-07-28
Characterizing the Neural Substrates of Irritability in Women: an Experimental Neuroendocrine Model
Leuprolide Acetate 3.75 MG/ML, Estradiol 2 Mg tablet, Micronized progesterone - Perinatal Depression, Post Partum Depression
Phase 2CompletedUniversity of North Carolina, Chapel Hill232020-01-022023-08-25
Ketamine to Improve Recovery After Cesarean Delivery - Part 1
Ketamine - Obstetric Pain, Postpartum Depression
Phase 2CompletedGrace Lim, MD, MS82019-10-092022-12-20
Tranexamic Acid for Prevention of Hemorrhage in Cesarean Delivery
Tranexamic Acid, Placebo - Post Partum Hemorrhage, Fibrinolysis; Hemorrhage
Phase 2 / Phase 3CompletedUniversity of Texas Southwestern Medical Center1102019-06-172021-01-19
Inhaled Oxytocin and HPA Axis Reactivity
Intranasal Oxytocin, Placebo - Depression, Postpartum, Anxiety Disorders
Phase 2CompletedUniversity of North Carolina, Chapel Hill1092019-02-072025-08-08
Efficacy of Ginger Extract (Compare Between the Ginger Preparation of Ancient Concept of Thai Traditional Practitioner, Standard Drug and Placebo) by Using Pain Score to Evaluate After Pain of Three Groups of First Normal Postpartum Women.
Ginger, Placebo oral capsule, Paracetamol - Postpartum Disorder
Phase 1 / Phase 2CompletedThammasat University992018-08-292019-05-29
Prevention of Postpartum Hemorrhage With Tranexamic Acid
Tranexamic Acid - Postpartum Hemorrhage
Phase 2CompletedGeorge Washington University432018-01-022025-03-25
A Clinical Trial of Oral Ganaxolone in Women With Postpartum Depression
Ganaxolone, Placebo - Depressive Disorder, Depression
Phase 2CompletedMarinus Pharmaceuticals842017-12-282023-08-18
A Clinical Trial of Intravenous (IV) Ganaxolone in Women With Postpartum Depression
Ganaxolone, Placebo - Depression, Depressive Disorder
Phase 2CompletedMarinus Pharmaceuticals912017-06-272023-07-19
Tranexamic Acid in Preventing Postpartum Hemorrhage in High Risk Pregnancies During Elective Cesarean Section
Tranexamic Acid - Postpartum Hemorrhage
Phase 2 / Phase 3CompletedMansoura University1402016-08-012017-11-27
Misoprostol+Oxytocin vs. Carbetocin in CS
Misoprostol, Oxytocin, Carbetocin - Cesarean Section
Phase 2 / Phase 3CompletedAin Shams University6002016-05-012020-07-08
Two Different Regimens of Misoprostol in Retained Placenta
Misoprostol - Postpartum Haemorrhage, Retained Placenta
Phase 2CompletedHawler Medical University5092016-03-012019-02-22
Preventing Postpartum Depression With Intranasal Oxytocin
Oxytocin, Placebo - Depression, Postpartum, Anxiety
Phase 2CompletedMassachusetts General Hospital562016-01-012025-02-25
A Study to Evaluate SAGE-547 in Participants With Severe Postpartum Depression
SAGE-547, Placebo - Severe Postpartum Depression
Phase 2CompletedSupernus Pharmaceuticals, Inc.212015-12-152025-09-15

Showing 20 of 45. Sign in to see all of them.

Narrower conditions

Depression, Postpartum (22)  ·  Postpartum Hemorrhage (19)  ·  Depression (8)  ·  Hemorrhage (3)  ·  Mental Disorders (3)  ·  Mood Disorders (3)  ·  Anxiety Disorders (2)  ·  Behavioral Symptoms (2)  ·  Breast Feeding (2)  ·  Depressive Disorder (2)  ·  Pregnancy Complications (2)  ·  Acute Pain (1)  ·  Anemia (1)  ·  Anemia, Neonatal (1)

Broader conditions

Female Urogenital Diseases and Pregnancy Complications (45)  ·  Urogenital Diseases (45)  ·  Pregnancy Complications (43)  ·  Depressive Disorder (20)  ·  Pathological Conditions, Signs and Symptoms (20)  ·  Mental Disorders (19)  ·  Mood Disorders (19)  ·  Obstetric Labor Complications (19)  ·  Pathologic Processes (19)  ·  Uterine Hemorrhage (19)  ·  Hemorrhage (16)  ·  Behavior (12)  ·  Behavioral Symptoms (7)  ·  Signs and Symptoms (4)

Interventions

Misoprostol (8)  ·  Oxytocin (7)  ·  Tranexamic Acid (5)  ·  Estradiol (2)  ·  Injections (2)  ·  Leuprolide (2)  ·  Progesterone (2)  ·  brexanolone (2)  ·  carbetocin (2)  ·  ganaxolone (2)  ·  Acetaminophen (1)  ·  Amoxicillin (1)  ·  Clavulanic Acid (1)  ·  Cloxacillin (1)  ·  Drugs, Generic (1)

Sponsors

Ain Shams University (3)  ·  Assiut University (2)  ·  Cairo University (2)  ·  Marinus Pharmaceuticals (2)  ·  Massachusetts General Hospital (2)  ·  Pakistan Institute of Living and Learning (2)  ·  Qazvin University Of Medical Sciences (2)  ·  Supernus Pharmaceuticals, Inc. (2)  ·  University of North Carolina, Chapel Hill (2)  ·  Women and Infants Hospital of Rhode Island (2)  ·  Aga Khan University (1)  ·  Al-Azhar University (1)  ·  Benha University (1)  ·  Brii Biosciences Limited (1)  ·  Copenhagen University Hospital at Herlev (1)

Countries

United States (19)  ·  Egypt (7)  ·  Iran (4)  ·  Pakistan (3)  ·  Canada (2)  ·  Brazil (1)  ·  China (1)  ·  Denmark (1)  ·  Iraq (1)  ·  Spain (1)  ·  Switzerland (1)  ·  Thailand (1)

Top investigators

Stephen J Kanes, MD, PhD (2)  ·  Alison M Stuebe, MD, MSc (1)  ·  Amgad E. Abou-Gamrah, Ass.Prof. (1)  ·  Anne J. Wikkelsoe, MD (1)  ·  Arash Afshari, MD (1)  ·  Ariana Kh. Jawad, Assistant professor (1)  ·  Arunporn Itharat, PH.D. (1)  ·  Bahar Q. Muhammad, CABOG (1)  ·  Batool Fatima (1)  ·  Beth A Lewis, PhD (1)  ·  Caron Zlotnick (1)  ·  Caron Zlotnick, PhD (1)  ·  Corrine K. Welt, MD (1)  ·  Crystal E Schiller, PhD (1)

Results publications

PMID 16390366, PMID 17650319, PMID 20455694, PMID 22805300, PMID 24880136, PMID 25586727, PMID 26454186, PMID 28480799, PMID 28619476, PMID 28707488, PMID 29316912, PMID 30447565, PMID 31598047, PMID 33078388, PMID 33181049, PMID 33248975, PMID 33705565, PMID 35038612, PMID 35141873, PMID 37626292, PMID 37883133, PMID 38709329, PMID 38767196

NIH funding

2009 (1), K23HL141640 (1), K23MH066265 (1), KL2TR001877 (1), R01HD093901 (1), R01MH071766 (1), R01MH074636 (1), R01MH074919 (1), R21HD090396 (1), R21MH085176 (1), R21MH119615 (1), UL1TR001876 (1)